Kevin P. Smith - 27 Feb 2026 Form 4 Insider Report for Inogen Inc (INGN)

Reporting relationship: EVP, Bus Dev, GC & Sec
Issuer ticker: INGN
Reported as of: 27 Feb 2026
Net transaction value: -$29,134
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:57:51 UTC
Prior SEC filing: 03 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Wright, as Attorney-in-Fact

Key filing fact

Kevin P. Smith filed Form 4 for Inogen Inc (INGN) on 03 Mar 2026.

Key facts

This page summarizes Kevin P. Smith's Form 4 filing for Inogen Inc (INGN).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Mar 2026, 16:57.

Change

Previous filing in this sequence was filed on 03 Sep 2025.
Current net transaction value: -$29,134.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002031211 Primary reporting owner

Smith Kevin P.

Relationship: EVP, Bus Dev, GC & Sec
Address: C/O INOGEN, INC., 500 CUMMING CENTER, SUITE 2800, BEVERLY
Signature: /s/ Mary Wright, as Attorney-in-Fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Award

Transaction value: $9,150
Shares: +1,500
Change %: +12%
Price: $6.10
Shares after: 14,278
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1

INGN transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +14,005
Change %: +98%
Price: $0.000000
Shares after: 28,283
Date: 01 Mar 2026
Ownership: Direct

INGN transaction

Common Stock

Tax liability

Transaction value: $38,284
Shares: -6,276
Change %: -22%
Price: $6.10
Shares after: 22,007
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +35,000
Change %
Price: $0.000000
Shares after: 35,000
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price
Footnotes: F3, F4

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -14,005
Change %: -33%
Price: $0.000000
Shares after: 28,011
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,005
Exercise price
Footnotes: F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

Footnote F2

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F4

Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

Footnote F5

1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.